-
1
-
-
66349090778
-
2 structure/function, mechanism, and signaling
-
2 structure/function, mechanism, and signaling. J Lipid Res 2009; 50 (Suppl.): S237-42.
-
(2009)
J Lipid Res
, vol.50
, Issue.SUPPL.
-
-
Burke, J.E.1
Dennis, E.A.2
-
2
-
-
0035976575
-
Prostaglandins and leukotrienes: Advances in eicosanoid biology
-
Funk CD,. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001; 294: 1871-5.
-
(2001)
Science
, vol.294
, pp. 1871-1875
-
-
Funk, C.D.1
-
5
-
-
0037162025
-
Lysophospholipids and their G protein-coupled receptors in inflammation and immunity
-
Graler MH, Goetzl EJ,. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta 2002; 1582: 168-74.
-
(2002)
Biochim Biophys Acta
, vol.1582
, pp. 168-174
-
-
Graler, M.H.1
Goetzl, E.J.2
-
6
-
-
73649118166
-
2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases
-
2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases. Expert Opin Ther Pat 2010; 20: 1-18.
-
(2010)
Expert Opin Ther Pat
, vol.20
, pp. 1-18
-
-
Magrioti, V.1
Kokotos, G.2
-
11
-
-
1342324060
-
2α reigns supreme in arthritis and bone resorption
-
2α reigns supreme in arthritis and bone resorption. Trends Immunol 2004; 25: 116-19.
-
(2004)
Trends Immunol
, vol.25
, pp. 116-119
-
-
Bonventre, J.1
-
13
-
-
2942527422
-
2 inhibitors - Reducing the lipophilicity of the arachidonyl chain isostere
-
2 inhibitors-reducing the lipophilicity of the arachidonyl chain isostere. Bioorg Med Chem Lett 2004; 14: 3645-9.
-
(2004)
Bioorg Med Chem Lett
, vol.14
, pp. 3645-3649
-
-
Walters, I.1
Bennion, C.2
Connolly, S.3
-
17
-
-
45749141743
-
2α inhibitors: Discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4- dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl} benzoic acid, efipladib
-
2α inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino} ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib. J Med Chem 2008; 51: 3388-413.
-
(2008)
J Med Chem
, vol.51
, pp. 3388-3413
-
-
McKew, J.C.1
Lee, K.L.2
Shen, M.W.3
-
18
-
-
38849174860
-
2α: Optimization of in vitro potency and rat pharmacokinetics for oral efficacy
-
2α: optimization of in vitro potency and rat pharmacokinetics for oral efficacy. Bioorg Med Chem 2008; 16: 1345-58.
-
(2008)
Bioorg Med Chem
, vol.16
, pp. 1345-1358
-
-
Lee, K.L.1
Behnke, M.L.2
Foley, M.A.3
-
19
-
-
77649104362
-
2α inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model
-
2α inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model. Inflamm Res 2010; 59: 53-62.
-
(2010)
Inflamm Res
, vol.59
, pp. 53-62
-
-
Tai, N.1
Kuwabara, K.2
Kobayashi, M.3
-
20
-
-
0034978804
-
2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models
-
2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. J Pharmacol Exp Ther 2001; 298: 376-85.
-
(2001)
J Pharmacol Exp Ther
, vol.298
, pp. 376-385
-
-
Burke, J.R.1
Davern, L.B.2
Stanley, P.L.3
-
23
-
-
77954755968
-
2α with reduced lipophilicity: Synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity
-
2α with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity. J Med Chem 2010; 53: 5165-78.
-
(2010)
J Med Chem
, vol.53
, pp. 5165-5178
-
-
Drews, A.1
Bovens, S.2
Roebrock, K.3
-
24
-
-
78649861774
-
2α: Effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability
-
2α: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability. J Med Chem 2010; 53: 8298-308.
-
(2010)
J Med Chem
, vol.53
, pp. 8298-8308
-
-
Bovens, S.1
Schulze Elfringhoff, A.2
Kaptur, M.3
-
25
-
-
0035176485
-
Different pathways leading to cutaneous leukocytoclastic vasculitis in mice
-
Sunderkötter C, Seeliger S, Schonlau F, et al. Different pathways leading to cutaneous leukocytoclastic vasculitis in mice. Exp Dermatol 2001; 10: 391-404.
-
(2001)
Exp Dermatol
, vol.10
, pp. 391-404
-
-
Sunderkötter, C.1
Seeliger, S.2
Schonlau, F.3
-
26
-
-
8744249915
-
Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis
-
Hyun E, Bolla M, Steinhoff M, et al. Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. Br J Pharmacol 2004; 143: 618-25.
-
(2004)
Br J Pharmacol
, vol.143
, pp. 618-625
-
-
Hyun, E.1
Bolla, M.2
Steinhoff, M.3
-
27
-
-
0027182472
-
MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner
-
Roth J, Burwinkel F, van den Bos C, et al. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993; 82: 1875-83.
-
(1993)
Blood
, vol.82
, pp. 1875-1883
-
-
Roth, J.1
Burwinkel, F.2
Van Den Bos, C.3
-
28
-
-
0027639996
-
The contact allergens nickel chloride and cobalt chloride directly induce expression of endothelial adhesion molecules
-
Goebeler M, Roth J, Meinardus-Hager G, Sorg C,. The contact allergens nickel chloride and cobalt chloride directly induce expression of endothelial adhesion molecules. Behring Inst Mitt 1993; 92: 191-201.
-
(1993)
Behring Inst Mitt
, vol.92
, pp. 191-201
-
-
Goebeler, M.1
Roth, J.2
Meinardus-Hager, G.3
Sorg, C.4
-
29
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method
-
Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-8.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
30
-
-
0019158157
-
A survey of transformation markers in differentiating epidermal cell lines in culture
-
Yuspa SH, Hawley-Nelson P, Koehler B, et al. A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res 1980; 40: 4694-703.
-
(1980)
Cancer Res
, vol.40
, pp. 4694-4703
-
-
Yuspa, S.H.1
Hawley-Nelson, P.2
Koehler, B.3
-
31
-
-
67650995959
-
High-performance liquid chromatographic assay with fluorescence detection for the evaluation of inhibitors against fatty acid amide hydrolase
-
Forster L, Schulze Elfringhoff A, Lehr M,. High-performance liquid chromatographic assay with fluorescence detection for the evaluation of inhibitors against fatty acid amide hydrolase. Anal Bioanal Chem 2009; 394: 1679-85.
-
(2009)
Anal Bioanal Chem
, vol.394
, pp. 1679-1685
-
-
Forster, L.1
Schulze Elfringhoff, A.2
Lehr, M.3
-
32
-
-
77049087509
-
High-performance liquid chromatography assay with fluorescence detection for the evaluation of inhibitors against human recombinant monoacylglycerol lipase
-
Holtfrerich A, Makharadze T, Lehr M,. High-performance liquid chromatography assay with fluorescence detection for the evaluation of inhibitors against human recombinant monoacylglycerol lipase. Anal Biochem 2010; 399: 218-24.
-
(2010)
Anal Biochem
, vol.399
, pp. 218-224
-
-
Holtfrerich, A.1
Makharadze, T.2
Lehr, M.3
-
33
-
-
0021798386
-
Topical glucocorticoids and suppression of contact sensitivity. A mouse bioassay of anti-inflammatory effects
-
Back O, Egelrud T,. Topical glucocorticoids and suppression of contact sensitivity. A mouse bioassay of anti-inflammatory effects. Br J Dermatol 1985; 112: 539-45.
-
(1985)
Br J Dermatol
, vol.112
, pp. 539-545
-
-
Back, O.1
Egelrud, T.2
-
34
-
-
0036153739
-
Topical peroxisome proliferator activated receptor-α activators reduce inflammation in irritant and allergic contact dermatitis models
-
Sheu MY, Fowler AJ, Kao J, et al. Topical peroxisome proliferator activated receptor-α activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 2002; 118: 94-101.
-
(2002)
J Invest Dermatol
, vol.118
, pp. 94-101
-
-
Sheu, M.Y.1
Fowler, A.J.2
Kao, J.3
-
35
-
-
0030827498
-
A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: In vivo pharmacology
-
Meingassner JG, Grassberger M, Fahrngruber H, et al. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology. Br J Dermatol 1997; 137: 568-76.
-
(1997)
Br J Dermatol
, vol.137
, pp. 568-576
-
-
Meingassner, J.G.1
Grassberger, M.2
Fahrngruber, H.3
-
36
-
-
0026645680
-
Expression of the calcium-binding proteins MRP8 and MRP14 by early infiltrating cells in experimental contact dermatitis
-
Roth J, Sunderkötter C, Goebeler M, et al. Expression of the calcium-binding proteins MRP8 and MRP14 by early infiltrating cells in experimental contact dermatitis. Int Arch Allergy Immunol 1992; 98: 140-5.
-
(1992)
Int Arch Allergy Immunol
, vol.98
, pp. 140-145
-
-
Roth, J.1
Sunderkötter, C.2
Goebeler, M.3
-
37
-
-
77957920202
-
Epidermal hyperplasia and elevated HB-EGF are more prominent in retinoid dermatitis compared with irritant contact dermatitis induced by benzalkonium chloride
-
Lee JE, Chang JY, Lee SE, et al. Epidermal hyperplasia and elevated HB-EGF are more prominent in retinoid dermatitis compared with irritant contact dermatitis induced by benzalkonium chloride. Ann Dermatol 2010; 22: 290-9.
-
(2010)
Ann Dermatol
, vol.22
, pp. 290-299
-
-
Lee, J.E.1
Chang, J.Y.2
Lee, S.E.3
-
38
-
-
0343457968
-
Epidermal cytokines in murine cutaneous irritant responses
-
Effendy I, Loffler H, Maibach HI,. Epidermal cytokines in murine cutaneous irritant responses. J Appl Toxicol 2000; 20: 335-41.
-
(2000)
J Appl Toxicol
, vol.20
, pp. 335-341
-
-
Effendy, I.1
Loffler, H.2
Maibach, H.I.3
-
39
-
-
0028322348
-
Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin
-
Wilmer JL, Burleson FG, Kayama F, et al. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J Invest Dermatol 1994; 102: 915-22.
-
(1994)
J Invest Dermatol
, vol.102
, pp. 915-922
-
-
Wilmer, J.L.1
Burleson, F.G.2
Kayama, F.3
-
40
-
-
0032555773
-
Selective induction of cell-associated interleukin-1α in murine keratinocytes by chemical allergens
-
Corsini E, Primavera A, Marinovich M, et al. Selective induction of cell-associated interleukin-1α in murine keratinocytes by chemical allergens. Toxicology 1998; 129: 193-200.
-
(1998)
Toxicology
, vol.129
, pp. 193-200
-
-
Corsini, E.1
Primavera, A.2
Marinovich, M.3
-
41
-
-
17044392271
-
ERK1/2 regulates epidermal chemokine expression and skin inflammation
-
Pastore S, Mascia F, Mariotti F, et al. ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 2005; 174: 5047-56.
-
(2005)
J Immunol
, vol.174
, pp. 5047-5056
-
-
Pastore, S.1
Mascia, F.2
Mariotti, F.3
-
42
-
-
77954037796
-
Keratinocytes determine Th1 immunity during early experimental leishmaniasis
-
Ehrchen JM, Roebrock K, Foell D, et al. Keratinocytes determine Th1 immunity during early experimental leishmaniasis. PLoS Pathog 2010; 6: e1000871.
-
(2010)
PLoS Pathog
, vol.6
-
-
Ehrchen, J.M.1
Roebrock, K.2
Foell, D.3
-
44
-
-
0030051933
-
Selective stimulation of cutaneous interleukin 6 expression by skin allergens
-
Holliday MR, Dearman RJ, Corsini E, et al. Selective stimulation of cutaneous interleukin 6 expression by skin allergens. J Appl Toxicol 1996; 16: 65-70.
-
(1996)
J Appl Toxicol
, vol.16
, pp. 65-70
-
-
Holliday, M.R.1
Dearman, R.J.2
Corsini, E.3
-
47
-
-
0034747079
-
2 for the treatment of inflammatory skin diseases
-
2 for the treatment of inflammatory skin diseases. Curr Opin Investig Drugs 2001; 2: 1549-52.
-
(2001)
Curr Opin Investig Drugs
, vol.2
, pp. 1549-1552
-
-
Burke, J.R.1
-
48
-
-
34848863139
-
Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors
-
Saario SM, Laitinen JT,. Therapeutic potential of endocannabinoid- hydrolysing enzyme inhibitors. Basic Clin Pharmacol Toxicol 2007; 101: 287-93.
-
(2007)
Basic Clin Pharmacol Toxicol
, vol.101
, pp. 287-293
-
-
Saario, S.M.1
Laitinen, J.T.2
|